What are cell-based assays?

Cell-based assays are laboratory techniques that use live cells to evaluate various biological processes, such as drug effectiveness, toxicity, and signaling pathways.

How big is the Cell-Based Assays Market?

The global Cell-Based Assays Market size was estimated at USD 16.3 billion in 2022 and is expected to reach USD 37.1 billion in 2032.

What is the Cell-Based Assays Market growth?

The global Cell-Based Assays Market is expected to grow at a compound annual growth rate of 8.8 %. From 2023 To 2032

Who are the key companies/players in the Cell-Based Assays Market?

Some of the key players in the Cell-Based Assays Markets are BD, Danaher Corporation, Corning Incorporated, Lonza Group, Thermo Fisher Scientific Inc., DiscoverX Corporation, Bio-Rad Laboratories, Inc., The Merck Group,, Charles River Laboratories, AAT Bioquest, Inc., Cell Signaling Technology, Inc., GE Healthcare, Other Key Players

Why are cell-based assays important?

Cell-based assays provide valuable insights into how drugs and compounds interact with living cells, helping in drug discovery, safety assessment, and understanding disease mechanisms.

What industries use cell-based assays?

Cell-based assays are widely used in pharmaceuticals, biotechnology, academic research, and toxicology to advance drug development and basic science.

Cell-Based Assays Market New Developments

Global Cell-Based Assays Market By Product & Service (Reagent, Assay Kits, Microplates, Probes & Labels, Instruments &Software, and Cell Lines), By Application (Basic Research, Drug Discovery, Other Application), By End-User By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032

- Get a FREE Sample -

Our Clients